Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032107-03
Application #
2067006
Study Section
Virology Study Section (VR)
Project Start
1994-02-01
Project End
1998-01-31
Budget Start
1996-02-01
Budget End
1998-01-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Pathology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Zapata, Juan C; Salvato, Maria S (2015) Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol 10:233-256
Lukashevich, Igor S; Djavani, Mahmoud; Rodas, Juan D et al. (2002) Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. J Med Virol 67:171-86
Djavani, M; Yin, C; Lukashevich, I S et al. (2001) Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J Hum Virol 4:103-8
Lukashevich, I S; Maryankova, R; Vladyko, A S et al. (1999) Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol 59:552-60
Borden, K L; Campbelldwyer, E J; Carlile, G W et al. (1998) Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72:3819-26
Borden, K L; Campbell Dwyer, E J; Salvato, M S (1998) An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758-66
Borden, K L; CampbellDwyer, E J; Salvato, M S (1997) The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett 418:30-4
Lukashevich, I S; Djavani, M; Shapiro, K et al. (1997) The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. J Gen Virol 78 ( Pt 3):547-51
Hildeman, D; Salvato, M; Whitton, J L et al. (1996) Vaccination protects beta 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection. Vaccine 14:1223-9